EQS-Adhoc
Symrise AG: CEO change at Symrise AG: Dr Heinz-Jürgen Bertram hands over to Dr Jean-Yves Parisot
Für Sie zusammengefasst
- Dr. Heinz-Jürgen Bertram hands over CEO role to Dr. Jean-Yves Parisot at Symrise AG.
- Dr. Jean-Yves Parisot will take over as CEO effective end of March 2024.
- Dr. Bertram retires in mutual agreement, Parisot's contract renewed until 2028.
EQS-Ad-hoc: Symrise AG / Key word(s): Personnel
Holzminden, 29 February 2024
Dr Jean-Yves Parisot has been a member of the Executive Board of Symrise AG since 2016, being responsible for the Taste, Nutrition & Health segment. He takes over as CEO from Dr Heinz-Jürgen Bertram, whose contract originally would have expired by end of October 2025 and who is now retiring in the best mutual consent and agreement. He will continue to work closely with Dr Jean-Yves Parisot to ensure a smooth handover. www.symrise.com Media contact: Investor Relations contact: Bernhard Kott Tobias Erfurth Tel.: +49 55 31 90-17 21 Tel.: +49 55 31 90-1879 Email: bernhard.kott@symrise.com Email: Tobias.Erfurth@symrise.com End of Inside Information
29-Feb-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Symrise AG |
Mühlenfeldstraße 1 | |
37603 Holzminden | |
Germany | |
Phone: | +49 (0)5531 90 0 |
E-mail: | ir@symrise.com |
Internet: | www.symrise.com |
ISIN: | DE000SYM9999, DE000SYM7787, DE000SYM7704 |
WKN: | SYM999 |
Indices: | DAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1848477 |
End of Announcement | EQS News Service |
|
1848477 29-Feb-2024 CET/CEST
Diskutieren Sie über die enthaltenen Werte
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte